Advertisement

Index by author

March 01, 1994; Volume 22,Issue 2

  1. Puhl, R J

    1. The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition March 1994, 22 (2) 233-236;

  2. Raberger, G

    1. NG-nitro-L-arginine is not involved in enterohepatic cycling in rats.
      V K Piotrovskij, Z Kállay, J Horecký, T Trnovec, G Raberger and K Krejcy
      Drug Metabolism and Disposition March 1994, 22 (2) 338-339;

  3. Ramjit, H G

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;

  4. Redza, Z M

    1. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
      P G Forkert, Z M Redza, S Mangos, S S Park and S P Tam
      Drug Metabolism and Disposition March 1994, 22 (2) 248-253;

  5. Regnier, B

    1. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.
      L Dalgaard, R K Hjortkjaer, B Regnier and L Nordholm
      Drug Metabolism and Disposition March 1994, 22 (2) 289-293;

  6. Ridley, W P

    1. Milacemide metabolism in rat liver and brain slices by solids NMR.
      J R Garbow, W P Ridley, V Bork, Y Pan and J Schaefer
      Drug Metabolism and Disposition March 1994, 22 (2) 298-303;

  7. Rooney, C S

    1. Metabolism of 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one (L-696,229), an HIV-1 reverse transcriptase inhibitor, by rat liver slices and in humans.
      S K Balani, L R Kauffman, B H Arison, T V Olah, M E Goldman, S L Varga, J A O'Brien, H G Ramjit, C S Rooney and J M Hoffman
      Drug Metabolism and Disposition March 1994, 22 (2) 200-205;

  8. Ross, D

    1. Solvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.
      X Cheng, C Maniglier-Poulet, D Ross and J A Ruth
      Drug Metabolism and Disposition March 1994, 22 (2) 206-210;

  9. Rubio, F

    1. Disposition of [14C]acitretin in humans following oral administration.
      F Rubio, B K Jensen, L Henderson, W A Garland, A Szuna and C Town
      Drug Metabolism and Disposition March 1994, 22 (2) 211-215;

  10. Ruth, J A

    1. Solvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.
      X Cheng, C Maniglier-Poulet, D Ross and J A Ruth
      Drug Metabolism and Disposition March 1994, 22 (2) 206-210;
« Previous (Pages : 5 6 7 8 9 10 11 12 ... 12) Next »
Back to top

In this issue

Advertisement